IP Library Assignment 063665/0335
Patent Assignment
Reel/Frame 063665/0335

Assignment of Assignor's Interest

Recorded: 2023-05-16 Pages: 14
Assignors
RADHAKRISHNAN, BALASINGAM
Executed: 2023-04-11
JAMES, KENNETH DUKE
Executed: 2023-04-13
VAIDYA, ANURADHA
Executed: 2023-05-02
POLOWY, KAREN
Executed: 2023-04-13
Assignee
SEACHAID PHARMACEUTICALS, INC.
PO BOX 488, MEBANE, NORTH CAROLINA, 27302
Covered Properties (2)
Dosing Regimens for Echinocandin Class Compounds
Patent: 9,526,835 →
Application: 14/386,266 →
Publication: US 2015/0087583
Dosing Regimens for Echinocandin Class Compounds
Application: 16/017,427 →
Publication: US 2019/0160141
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 30, 2015
From: RADHAKRISHNAN, BALASINGAM; JAMES, KENNETH DUKE, JR.; VAIDYA, ANURADHA; POLOWY, KAREN
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 034854/0480 →
Assignment of Assignor's Interest Jan 30, 2015
From: SEACHAID PHARMACEUTICALS, INC.
To: CIDARA THERAPEUTICS, INC.
Reel/Frame 034854/0735 →
Assignment of Assignor's Interest Feb 15, 2019
From: SEACHAID PHARMACEUTICALS, INC.
To: CIDARA THERAPEUTICS, INC.
Reel/Frame 048345/0535 →
Change of Name Feb 15, 2019
From: K2 THERAPEUTICS, INC.
To: CIDARA THERAPEUTICS, INC.
Reel/Frame 048356/0440 →
Assignment of Assignor's Interest Feb 15, 2019
From: SEACHAID PHARMACEUTICALS, INC.
To: K2 THERAPEUTICS, INC.
Reel/Frame 048345/0329 →
Assignment of Assignor's Interest Feb 15, 2019
From: RADHAKRISHNAN, BALASINGAM; JAMES, KENNETH DUKE, JR.; VAIDYA, ANURADHA; POLOWY, KAREN
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 048345/0074 →
Assignment of Assignor's Interest Jan 31, 2023
From: RADHAKRISHNAN, BALASINGAM; JAMES, KENNETH DUKE, JR.; VAIDYA, ANURADHA; POLOWY, KAREN
To: SEACHAID PHARMACEUTICALS, INC.
Reel/Frame 062541/0365 →
Assignment of Assignor's Interest Oct 22, 2024
From: CIDARA THERAPEUTICS, INC.
To: NAPP PHARMACEUTICAL GROUP LIMITED
Reel/Frame 069208/0471 →
Assignment of Assignor's Interest Mar 27, 2026
From: CIDARA THERAPEUTICS, INC.
To: NAPP PHARMACEUTICAL GROUP LIMITED
Reel/Frame 075286/0638 →